This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, X.
Right arrow Articles by Rodriguez, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, X.
Right arrow Articles by Rodriguez, M.

 Previous Article  |  Next Article 

J Virol, February 1998, p. 1262-1269, Vol. 72, No. 2
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Molecular Characterization of a Nondemyelinating Variant of Daniel's Strain of Theiler's Virus Isolated from a Persistently Infected Glioma Cell Line

Xiaoqi Lin,1,2 Shigeru Sato,3 Amy K. Patick,2,dagger Larry R. Pease,1 Raymond P. Roos,3 and Moses Rodriguez1,2,*

Departments of Immunology1 and Neurology,2 Mayo Clinic, Rochester, Minnesota 55905, and Department of Neurology, University of Chicago Medical Center, Chicago, Illinois 606373

Received 10 June 1997/Accepted 16 October 1997

Wild-type Daniel's strain of Theiler's virus (wt-DA) induces a chronic demyelination in susceptible mice which is similar to multiple sclerosis. A variant of wt-DA (designated DA-P12) generated during the 12th passage of persistent infection of a G26-20 glioma cell line failed to persist and induce demyelination in SJL/J mice. To identify the determinants responsible for this change in phenotype, we sequenced the capsid coding sequence (nucleotides [nt] 2991 to 3994) and found three mutations in VP1: residues 99 (Gly to Ser), 100 (Gly to Asp), and 103 (Asn to Lys). To study the role of these mutations in neurovirulence and demyelination, we prepared a recombinant virus, DAP-1C-2A/DA, with replacement of wt-DA nt 2991 to 3994 with the corresponding region of DA-P12, and viruses with individual point mutations at VP1 residues 99(Ser), 100(Asp), and 103(Lys). DAP-1C-2A/DA and viruses with a mutation at VP1 residue 99 or 100 (but not 103) completely attenuated the ability of wt-DA to induce demyelination. Failure to induce demyelination was not due to a general failure in growth, since DA-P12 and other mutant viruses lysed L-2 cells in vitro as effectively as wt-DA. The change in disease phenotype was independent of the specific B- or T-cell immune recognition because a decrease in the neurovirulence of mutant viruses was observed in neonatal mice and immune-deficient RAG1 -/- mice. This difference in neurovirulence is not the complete explanation for the failure of DA-P12 to demyelinate, since virus with a mutation at residue 103(Lys) had decreased neurovirulence but did induce demyelination. Therefore, point mutation at VP1 residue 99 or 100 altered the ability of wt-DA to demyelinate, perhaps related to a disruption in interaction between virus and receptor on certain neural cells.


* Corresponding author. Mailing address: Departments of Neurology and Immunology, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905. Phone: (507) 284-5365. Fax: (507) 284-1637. E-mail: rodriguez{at}rcf.mayo.edu.

dagger Present address: Agouron Pharmaceuticals, Inc., San Diego, CA 92121.




This article has been cited by other articles:

  • Lin, X., Ma, X., Rodriguez, M., Feng, X., Zoecklein, L., Fu, Y.-X., Roos, R. P. (2003). Membrane lymphotoxin is required for resistance to Theiler's virus infection. Int Immunol 15: 955-962 [Abstract] [Full Text]  
  • Tsunoda, I., Wada, Y., Libbey, J. E., Cannon, T. S., Whitby, F. G., Fujinami, R. S. (2001). Prolonged Gray Matter Disease without Demyelination Caused by Theiler's Murine Encephalomyelitis Virus with a Mutation in VP2 Puff B. J. Virol. 75: 7494-7505 [Abstract] [Full Text]  
  • Drescher, K. M., Johnston, S. L., Hogancamp, W., Nabozny, G. H., David, C. S., Rimm, I. J., Wettstein, P. J., Rodriguez, M. (2000). V{beta}8+ T cells protect from demyelinating disease in a viral model of multiple sclerosis. Int Immunol 12: 271-280 [Abstract] [Full Text]  
  • McCright, I. J., Tsunoda, I., Whitby, F. G., Fujinami, R. S. (1999). Theiler's Viruses with Mutations in Loop I of VP1 Lead to Altered Tropism and Pathogenesis. J. Virol. 73: 2814-2824 [Abstract] [Full Text]  
  • Pilipenko, E. V., Viktorova, E. G., Khitrina, E. V., Maslova, S. V., Jarousse, N., Brahic, M., Agol, V. I. (1999). Distinct Attenuation Phenotypes Caused by Mutations in the Translational Starting Window of Theiler's Murine Encephalomyelitis Virus. J. Virol. 73: 3190-3196 [Abstract] [Full Text]